Management Team
DR. CHRISTOPHER TING
GROUP MD/CEO
- Co-founder of Biomark and CEO of Innovative Diagnostics
- Founder of Quantum Diagnostics
- Former CEO of Quest Laboratories and Gribbles Pathology
- Previously Assistant Head (Biomedical Sciences Group) at the Economic Development Board of Singapore
- Member in Malaysia’s National Key Economic Area (NKEA) Healthcare initiative
NABIL FAWZI
GROUP DEPUTY CEO / CFO
- Over 18 years of corporate experience including 8 years of Corporate Finance and Mergers & Acquisitions expertise
- Previously led EY Asia Pacific’s healthcare CF/M&A space
- Also served with PwC Singapore and UEM Group, a subsidiary of Khazanah Nasional
RAJKUMAR RENGARAJU
GROUP COO
- More than 18 years of experience in the medical laboratory industry
- Spearheaded multiple quality initiatives including CAP and ISO 15189 accreditation; and Westgard Verification
- Led and managed multiple mergers and laboratory rollout’s
CHRIS SKENNERTON
Group CTO
- 30 years in digital innovation and transformation, operations, software engineering and lab information systems
- Previously with 4Cyte Pathology, Healius, GE Healthcare and Royal Australian Air Force
MARTIN GIDDY
GROUP PMO
- Has over 30 years of experience in medical laboratory operations, in university teaching hospitals and private laboratories
- Previously CEO of Quantum Diagnostics and GM of Gribbles
- Managed the implementation of NATA and Standard Malaysia’s ISO 17025 and ISO 15189 accreditations for Gribbles Pathology